NAS10029,644+0.67%S&P7,651+0.17%GOLD$4,416+0.37%BTC$81,118+6.17%VIX14.81−4.08%live tape · as of 21:00 UTC
The Screen · Consumer Defensive · Packaged Foods
JBS NV
JBS · the NYSE · USD · Market cap $13.5B · 283,000 employees
JBS N.V., together with its subsidiaries, engages in the processing of animal proteins, encompassing activities related to beef, pork, lamb, and poultry worldwide.
FAIL · Does not pass the screen
12.59 USD
At the last full screen 2026-09-11
Screened 2026-09-11 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
JBS NV holds its Markdown at $12.59. Elevated stress, defensive posture warranted, held for 14 days.
As held on the ledger · 2026-09-11
Phase
Markdown · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 14 days
Price at the screen
$12.59
Valuation
11.77 trailing · 9.17 forward price to earnings
Values screen
FAIL· score 70.0
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
50.62%
Below 33%
Interest-bearing debt is 50.6% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.10%
Below 33%
Cash held in interest-bearing accounts and securities is 0.1% of assets, under the one-third limit.
Pass
Receivables
19.48%
Below 49%
Money owed to the company is 19.5% of assets, under the 49% limit.
Pass
Revenue purity
0.48%
Below 5%
Only 0.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. A 66.1% margin of safety to the base estimate.
Third-party analyst targets: 14 covering, consensus None. The average target sits +45% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Global meat plants priced like broken assets
Picture the supply chain behind every supermarket sausage or takeaway burger. JBS runs the plants that turn cattle, pigs and chickens into packaged protein across dozens of countries. The shares sit at an 83 percent discount to our fair value while revenue climbs 11 percent and return on equity hits 22 percent.
A forward multiple of 6.8 times and a narrow moat still leave room for solid cash generation in a defensive category. Fourteen analysts carry a buy consensus with a median target of 19 dollars, and the business clears our ethical screen.
Low single-digit margins and commodity price swings create real cyclical risk. Peak earnings can flatter the multiple and turn an apparent bargain into a trap. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Netherlands and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
JBS trades on the NYSE (the company is based in Netherlands). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (15 analysts) rates it strong buy, with a mean price target of $19.
2026-08-03Markup · changed$13.55+8.1%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (15 analysts) rates it strong buy, with a mean price target of $19.
2026-07-18Distribution$12.54+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (15 analysts) rates it strong buy, with a mean price target of $19.
2026-07-03Distribution$12.54+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Distribution$12.54Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.